TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

SKYE FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Rosen Law Firm
SKYE FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Skye Bioscience, Inc. Investors to Secure Counsel Before Important January 16 Deadline in Securities Class Action – SKYE

Rosen Law Firm is reminding investors in Skye Bioscience, Gauzy Ltd., and Stride, Inc. of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made materially false and misleading statements regarding their business operations and prospects. Investors who purchased securities during specified class periods may be entitled to compensation.

Insights
JPM   neutral

Serving as lead book-running manager for the offering, indicating a standard financial service role


SKYE   negative

Company is subject to securities class action lawsuit alleging materially false and misleading statements regarding nimacimab's effectiveness and commercial prospects, resulting in investor damages.